Search results

• 2013

  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE

  EMBRACE, 5 Jun 2013, In: Journal of the National Cancer Institute. 105, 11, p. 812-22 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Analysis 100%
  • Breast Cancer 100%
  • Cancer Risk 100%
  • Ovarian Cancer 35%
  • Contralateral 28%
  737 Citations (Scopus)

• Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

  Ruark, E., Snape, K., Humburg, P., Loveday, C., Bajrami, I., Brough, R., Rodrigues, D. N., Renwick, A., Seal, S., Ramsay, E., Duarte, S. D. V., Rivas, M. A., Warren-Perry, M., Zachariou, A., Campion-Flora, A., Hanks, S., Murray, A., Ansari Pour, N., Douglas, J. & Gregory, L. & 30 others, Rimmer, A., Walker, N. M., Yang, T.-P., Adlard, J. W., Barwell, J., Berg, J., Brady, A. F., Brewer, C., Brice, G., Chapman, C., Cook, J., Davidson, R., Donaldson, A., Douglas, F., Eccles, D., Evans, D. G., Greenhalgh, L., Henderson, A., Izatt, L., Kumar, A., Lalloo, F., Miedzybrodzka, Z., Morrison, P. J., Paterson, J., Porteous, M., Rogers, M. T., Shanley, S., Walker, L., Gore, M. & Breast and Ovarian Cancer Susceptibility Collaboration, 17 Jan 2013, In: NATURE. 493, 7432, p. 406-10 5 p.

  Research output: Contribution to journal › Letter › peer-review

  • Protein 100%
  • Sequencing 60%
  • Genetic Divergence 40%
  • Gene 40%
  • Isoform 20%
  206 Citations (Scopus)